Skip to content

Clinical trials

Phase 3 Cardiovascular Diseases trials in Lithuania

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Phase 3 Country / region: Lithuania Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20071
20111
20123
20161
20171
20182
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated4
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Eli Lilly and Company2
Amgen1
Boehringer Ingelheim1
CSL Behring1
Esperion Therapeutics, Inc.1
Heidelberg University1
Hoffmann-La Roche1
Remedy Pharmaceuticals, Inc.1
Solvay Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases14
Diabetes Mellitus, Type 25
Heart Failure3
Hypertension3
Stroke3
Coronary Artery Disease2
Acute Coronary Syndrome1
Anemia1
Atherosclerosis1
Atrial Fibrillation1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.